| Literature DB >> 28273452 |
Koen M A Dreijerink1, Anna C Groner1, Erica S M Vos2, Alba Font-Tello1, Lei Gu3, David Chi1, Jaime Reyes4, Jennifer Cook1, Elgene Lim1, Charles Y Lin4, Wouter de Laat2, Prakash K Rao1, Henry W Long1, Myles Brown5.
Abstract
While the multiple endocrine neoplasia type 1 (MEN1) gene functions as a tumor suppressor in a variety of cancer types, we explored its oncogenic role in breast tumorigenesis. The MEN1 gene product menin is involved in H3K4 trimethylation and co-activates transcription. We integrated ChIP-seq and RNA-seq data to identify menin target genes. Our analysis revealed that menin-dependent target gene promoters display looping to distal enhancers that are bound by menin, FOXA1 and GATA3. In this fashion, MEN1 co-regulates a proliferative breast cancer-specific gene expression program in ER+ cells. In primary mammary cells, MEN1 exerts an anti-proliferative function by regulating a distinct expression signature. Our findings clarify the cell-type-specific functions of MEN1 and inform the development of menin-directed treatments for breast cancer.Entities:
Keywords: MEN1; breast cancer; enhancer; epigenetics; histone H3K4 trimethylation; menin; oncogene; transcription; tumor suppressor
Mesh:
Substances:
Year: 2017 PMID: 28273452 PMCID: PMC5609449 DOI: 10.1016/j.celrep.2017.02.025
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423